Literature DB >> 19564388

Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans.

John J Osterholzer1, Jami E Milam, Gwo-Hsiao Chen, Galen B Toews, Gary B Huffnagle, Michal A Olszewski.   

Abstract

Successful pulmonary clearance of the encapsulated yeast Cryptococcus neoformans requires a T1 adaptive immune response. This response takes up to 3 weeks to fully develop. The role of the initial, innate immune response against the organism is uncertain. In this study, an established model of diphtheria toxin-mediated depletion of resident pulmonary dendritic cells (DC) and alveolar macrophages (AM) was used to assess the contribution of these cells to the initial host response against cryptococcal infection. The results demonstrate that depletion of DC and AM one day prior to infection results in rapid clinical deterioration and death of mice within 6 days postinfection; this effect was not observed in infected groups of control mice not depleted of DC and AM. Depletion did not alter the microbial burden or total leukocyte recruitment in the lung. Mortality (in mice depleted of DC and AM) was associated with increased neutrophil and B-cell accumulation accompanied by histopathologic evidence of suppurative neutrophilic bronchopneumonia, cyst formation, and alveolar damage. Collectively, these data define an important role for DC and AM in regulating the initial innate immune response following pulmonary infection with C. neoformans. These findings provide important insight into the cellular mechanisms which coordinate early host defense against an invasive fungal pathogen in the lung.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564388      PMCID: PMC2737986          DOI: 10.1128/IAI.00454-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  79 in total

Review 1.  Dendritic cells: translating innate to adaptive immunity.

Authors:  R M Steinman; H Hemmi
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 2.  Dendritic cells in asthma and COPD: opportunities for drug development.

Authors:  Mirjam Kool; Bart N Lambrecht
Journal:  Curr Opin Immunol       Date:  2007-10-30       Impact factor: 7.486

Review 3.  Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases.

Authors:  Leonie M van Duivenvoorde; Geertje J D van Mierlo; Zita F H M Boonman; René E M Toes
Journal:  Immunobiology       Date:  2006-07-05       Impact factor: 3.144

Review 4.  Immunotherapy with dendritic cells for cancer.

Authors:  Alberto Ballestrero; Davide Boy; Eva Moran; Gabriella Cirmena; Peter Brossart; Alessio Nencioni
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

Review 5.  Dendritic cells in cancer immunotherapy.

Authors:  Annelie Vulink; Kristen J Radford; Cornelis Melief; Derek N J Hart
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

6.  Cryptococcus neoformans activates bone marrow-derived conventional dendritic cells rather than plasmacytoid dendritic cells and down-regulates macrophages.

Authors:  Sabine Siegemund; Gottfried Alber
Journal:  FEMS Immunol Med Microbiol       Date:  2008-04

7.  FMS-like tyrosine kinase 3 ligand aggravates the lung inflammatory response to Streptococcus pneumoniae infection in mice: role of dendritic cells.

Authors:  Christine Winter; Katharina Taut; Florian Länger; Matthias Mack; David E Briles; James C Paton; Regina Maus; Mrigank Srivastava; Tobias Welte; Ulrich A Maus
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

8.  Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector.

Authors:  Jami E Milam; Amy C Herring-Palmer; Raj Pandrangi; Roderick A McDonald; Gary B Huffnagle; Galen B Toews
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

9.  Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2-CCR2 axis.

Authors:  Christine Winter; Katharina Taut; Mrigank Srivastava; Florian Länger; Matthias Mack; David E Briles; James C Paton; Regina Maus; Tobias Welte; Michael D Gunn; Ulrich A Maus
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

10.  Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway.

Authors:  Kiwamu Nakamura; Akiko Miyazato; Gang Xiao; Masumitsu Hatta; Ken Inden; Tetsuji Aoyagi; Kohei Shiratori; Kiyoshi Takeda; Shizuo Akira; Shinobu Saijo; Yoichiro Iwakura; Yoshiyuki Adachi; Naohito Ohno; Kazuo Suzuki; Jiro Fujita; Mitsuo Kaku; Kazuyoshi Kawakami
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more
  63 in total

Review 1.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

2.  Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans.

Authors:  Carolina Coelho; Ana Camila Oliveira Souza; Lorena da Silveira Derengowski; Carlos de Leon-Rodriguez; Bo Wang; Rosiris Leon-Rivera; Anamelia Lorenzetti Bocca; Teresa Gonçalves; Arturo Casadevall
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

3.  Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.

Authors:  Takeshi Mimura; Natalie Walker; Yoshiro Aoki; Casey M Manning; Benjamin J Murdock; Jeffery L Myers; Amir Lagstein; John J Osterholzer; Vibha N Lama
Journal:  Am J Pathol       Date:  2015-04-04       Impact factor: 4.307

4.  Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.

Authors:  Michael J Davis; Alison J Eastman; Yafeng Qiu; Brian Gregorka; Thomas R Kozel; John J Osterholzer; Jeffrey L Curtis; Joel A Swanson; Michal A Olszewski
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

5.  Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization.

Authors:  Alison J Eastman; Xiumiao He; Yafeng Qiu; Michael J Davis; Priya Vedula; Daniel M Lyons; Yoon-Dong Park; Sarah E Hardison; Antoni N Malachowski; John J Osterholzer; Floyd L Wormley; Peter R Williamson; Michal A Olszewski
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

6.  Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice.

Authors:  André P Tittel; Christoph Heuser; Christina Ohliger; Chrystel Llanto; Simon Yona; Günter J Hämmerling; Daniel R Engel; Natalio Garbi; Christian Kurts
Journal:  Nat Methods       Date:  2012-02-26       Impact factor: 28.547

7.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

8.  Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans.

Authors:  Cheryl D Chun; Hiten D Madhani
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

9.  Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes.

Authors:  John J Osterholzer; Gwo-Hsiao Chen; Michal A Olszewski; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  CD11c+ cells are required to prevent progression from local acute lung injury to multiple organ failure and death.

Authors:  Jami E Milam; John R Erb-Downward; Gwo-Hsiao Chen; Marcin F Osuchowski; Roderick McDonald; Stephen W Chensue; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.